Brief: Preciseonco Research Consortium Awarded EUR 14.9 Million Grant In Precision Cancer Treatment
03/02/2026 09:05
Feb 3 (Reuters) - Koninklijke Philips NV PHG.AS: PRECISEONCO RESEARCH CONSORTIUM AWARDED EUR 14.9 MILLION IHI GRANT TO DRIVE BREAKTHROUGHS IN PRECISION CANCER TREATMENT CO-FUNDED BY EU'S INNOVATIVE HEALTH INITIATIVE (IHI) EUR 14.9 MILLION PUBLIC FUNDING WILL BE COMPLEMENTED BY EUR 9 MILLION IN IN-KIND CONTRIBUTIONS AND ADDITIONAL RESOURCES FROM INDUSTRY PARTNERS Source text: [ID:] Further company coverage: PHG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Koninklijke Philips
See all newsBrief: Philips Launches Hypervue Integrated System In The U.S., Bringing Advanced Coronary Imaging And Physiology Into The Cathlab
Citi lifts ResMed's ASX-listed stock's target price after FX, valuation updates
Philips wins Dutch court battle with shareholders over recall
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct